GSK plc
- SEC CIK
- 0001131399
- Latest filing
- Aug 13, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Feb 12, 2026. Long positions only.
- Positions
- 15
- No filing for Q3 2025
- Portfolio value
- $799.0M
- No filing for Q3 2025
GSK plc did not file a 13F for Q3 2025, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| WVEWave Life Sciences, Inc. | SHS | 18,245,691 | $310.2M | 38.8% | – | – | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 3,220,627 | $168.9M | 21.1% | – | – | History |
| BNTXBioNTech SE | SPONSORED ADS | 889,824 | $84.7M | 10.6% | – | – | History |
| VIRVir Biotechnology, Inc. | COM | 8,550,954 | $51.6M | 6.5% | – | – | History |
| LYELLyell Immunopharma, Inc. | COM NEW | 1,512,659 | $46.6M | 5.8% | – | – | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 1,333,333 | $46.1M | 5.8% | – | – | History |
| CYTKCytokinetics Inc | COM NEW | 340,434 | $21.6M | 2.7% | – | – | History |
| SPROSpero Therapeutics, Inc. | COM | 9,190,606 | $21.4M | 2.7% | – | – | History |
| FULCFulcrum Therapeutics, Inc. | COM | 1,785,714 | $20.2M | 2.5% | – | – | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 1,529,561 | $10.8M | 1.4% | – | – | History |
| CVRXCVRx, Inc. | COM | 1,007,583 | $7.15M | 0.9% | – | – | History |
| NKTXNkarta, Inc. | COM | 3,150,732 | $5.83M | 0.7% | – | – | History |
| RGNXREGENXBIO Inc. | COM | 271,456 | $3.91M | 0.5% | – | – | History |
| SENSSenseonics Holdings, Inc. | COM | 10,856 | $59.9K | <0.1% | – | – | History |
| HBIOHarvard Bioscience Inc | COM | 11,151 | $7.46K | <0.1% | – | – | History |